Mangosteen Extract MarketSize, Share & Industry Analysis, 2026-2034By TypeBy ApplicationBy FormBy Extraction MethodBy Distribution Channel

Mangosteen extract is a plant-derived ingredient obtained from the rind of the mangosteen fruit, valued for its concentrated xanthone and antioxidant content, and supplied as a powder or liquid concentrate. Buyers are formulators of cosmetics, functional foods and beverages, and dietary supplements, along with smaller volumes going to pharmaceutical and nutraceutical researchers. Purchasers range from large personal care and food manufacturers sourcing standardized bulk material to smaller supplement brands buying through ingredient distributors and online marketplaces.

Between 2025 and 2034 the global mangosteen extract market moves from USD 395 million to USD 740 million, compounding at 7.08% a year. Fifteen years are covered in all, taking in USD 245 million in 2020, USD 351 million in 2024, USD 428 million in 2026 and USD 568 million in 2030.

On the type axis, growth rates run from 4.78% for Synthetic up to 7.78% for Organic. Organic carries the volume: USD 294.28 million and 74.5% of revenue in 2025, USD 584.6 million and 79% in 2034. Organic take share over the period; Synthetic give it up while still growing in absolute terms.

The application split puts Cosmetic Industry first, at USD 158 million and 40% of revenue in 2025, rising to USD 281.2 million and 38% in 2034. Pharmaceutical grows faster at 9.01% against 6.61%, moving from 25% of revenue to 29% by 2034. It cuts the same total as the type axis from a different commercial angle, so revenue does not add across the two.

The regional order runs from Asia Pacific at 42% of 2025 revenue down to Middle East and Africa at 6%. Asia Pacific is worth USD 165.9 million in 2025 and USD 325.6 million in 2034; North America, second at 24%, moves from USD 94.8 million to USD 162.8 million. Because Asia Pacific, Latin America and Middle East and Africa take share, the revenue added by 2034 concentrates instead of spreading across all five regions.

The 2025 total is a triangulation of published figures and category proxies, short of a directly sourced total. Segment, regional and country splits are estimated on the same basis, which bounds the precision of the figures above. Coverage runs to five regions, two type lines and five segmentation axes across a fifteen-year window.

• A forecast-period rate of 7.08% takes the market from USD 395 million in 2025 to USD 740 million in 2034, against 10.02% recorded over the 2020-2025 historical period.
• 74.5% of 2025 revenue sits in Organic (USD 294.28 million) and it remains the largest type line in 2034 at USD 584.6 million and 79%.
• Scenario range for 2034 runs from USD 690 million in the bear case to USD 808 million in the bull case, against a base-case USD 740 million, the spread a plan built on this forecast has to absorb.
• The largest region is Asia Pacific, generating USD 165.9 million in 2025 (42% of the global total) and USD 325.6 million by 2034, ahead of North America at 24%.
• 35% of Asia Pacific's base-year revenue comes from China alone: USD 58.07 million in 2025, rising to USD 117.22 million by 2034, which is why it is that region's worked example.
• Every line on all five segmentation axes and in each of the five regions carries its own revenue, share and growth rate for all fifteen years, 2020 through 2034, on a 2025 base.

Three movements define the forecast period in the global mangosteen extract market: how the type mix changes, where regional weight shifts, and the rate at which the total compounds.

The direction of the market is not in question in any of the three. Each line and each region grows in revenue terms; what separates them is which takes the larger part of the growth.

The type mix tilts toward Organic. Between 2026 and 2034, 7.78% growth in Organic against 4.78% in Synthetic pulls the type mix apart. Shares follow: 74.5% to 79% for Organic, 25.5% to 21% for Synthetic. The revenue figures behind that are USD 294.28 million to USD 584.6 million and USD 100.73 million to USD 155.4 million. Both expand; where a supplier sits on the axis still decides whether it tracks the market.

Asia Pacific, Latin America and Middle East and Africa gain regional share. Asia Pacific moves from 42% of revenue in 2025 to 44% in 2034, worth USD 165.9 million rising to USD 325.6 million; Latin America moves from 8% of revenue in 2025 to 8.5% in 2034, worth USD 31.6 million rising to USD 62.9 million; Middle East and Africa moves from 6% of revenue in 2025 to 6.5% in 2034, worth USD 23.7 million rising to USD 48.1 million. The remaining regions grow in absolute terms while giving up share: North America at 24% moving to 22%, Europe at 20% moving to 19%. That makes the regional split worth reading directly instead of scaling from the global rate: the same market rate produces different outcomes depending on where a supplier's revenue sits.

Fifteen years without a discontinuity. Year by year the total runs USD 245 million in 2020, USD 351 million in 2024, USD 395 million in 2025, USD 428 million in 2026, USD 568 million in 2030 and USD 740 million in 2034. There is no discontinuity to time, and 7.08% forecast growth against 10.02% historical means the trend continues and does not turn. For a participant that makes planning a question of capturing a share of steady expansion instead of timing a discontinuity, and it is why the type and regional mixes matter more to a forecast than the headline rate does.

Organic carries the market's growth rate

The 7.08% forecast rate rests on three things that can be measured separately: the size of the existing base, the mix shift on the type axis, and where regional growth is concentrated.

The bear case and what drives it

What the bull case turns on

Revenue is concentrated in Organic

42% of the global mangosteen extract market sits in Asia Pacific in 2025, worth USD 165.9 million on the way to USD 325.6 million by 2034. Among the five regions it ranks first by revenue in both years.

Its share rises to 44% over the forecast period, on growth above the market's own 7.08%, and with a bigger contribution to the revenue added over the period than the base-year figure suggests.

The type mix reported at global level applies here, with Organic the largest line at 74.5% of 2025 revenue and Organic the fastest-growing at 7.78%. Revenue for Asia Pacific is broken out by every segmentation axis and by country in the full report.

The largest single market in Asia Pacific is China, at USD 58.07 million in 2025 and USD 117.22 million in 2034. Its 35% of base-year regional revenue leads the region, though enough sits elsewhere that Asia Pacific is not a proxy for it. Regional revenue of USD 165.9 million in 2025 and USD 325.6 million in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.

Demand in China follows the type mix reported at global level: Organic is the largest line at 74.5% of 2025 revenue, moving to 79% by 2034, while Organic grows fastest at 7.78% and takes its share from 74.5% to 79%. Its 35% weight in Asia Pacific means those movements carry straight into the regional totals. Per-type revenue for China appears on its own in the full report.

Mangosteen extract sold as a food ingredient or dietary supplement in China falls under the State Administration for Market Regulation, which oversees food safety standards and health food registration. A product marketed with specific health claims must go through the health food (baojianpin) registration or notification pathway administered under the State Administration for Market Regulation, requiring safety and efficacy documentation before sale. Ingredients without prior use history in China may also need novel food approval from the National Health Commission. Labelling must comply with national food safety standards covering ingredient disclosure, nutrition information, and any permitted function claims, and importers must ensure batches clear customs inspection against these same standards. Extracts marketed as general food ingredients rather than supplements face a lighter compliance burden but still answer to the same food safety authority.

Competition in China runs between the suppliers this study tracks: Premier Specialties Inc., Carrubba Inc., Dermalab, Natural Remedies Private Limited, Shenzhen Sendi Biotechnology Co.Ltd., Wuhan Fortuna Chemical Co. Ltd., Changsha Staherb Natural Ingredients Co. Ltd., Wuhan Yuancheng Gongchuang Technology Co.Ltd., Shaanxi Kingsci Biotechnology Co. Ltd., Xi'an Changyue Phytochemistry Co. Ltd., Xi&rsquo, an DN Biology Co. Ltd., Andy Biotech (Xi&rsquo, an) Co. Ltd. and Guilin Layn Natural Ingredients Corp.and others.. Organic is where the volume is, at 74.5% of 2025 revenue, and it is growing fastest as well at 7.78%. Country-level positioning and shares for each of these companies are part of the full report, not of this summary.

Within Asia Pacific, Thailand accounts for 25% of regional revenue and 10.5% of the global total, worth USD 41.48 million in 2025 and USD 78.14 million by 2034.

India is sized at USD 24.89 million in 2025, rising to USD 52.1 million by 2034; 6.3% of global revenue and 15% of Asia Pacific. It is reported separately from China across every segmentation axis in the full report.

In North America, 24% of global revenue puts 2025 at USD 94.8 million on the way to USD 162.8 million by 2034. Among the five regions it ranks second by revenue in both years.

22% of global revenue sits here in 2034, below the 2025 level, while nothing contracts here; other regions simply grow faster, which shows up as relative weight, not as falling revenue.

Within the region the type split tracks the global one; 74.5% of 2025 revenue in Organic, fastest growth of 7.78% in Organic. North America is reported axis by axis and country by country in the full study.

The largest single market in North America is the United States, at USD 73.94 million in 2025 and USD 126.98 million in 2034. 78% of the region in 2025 means the regional figures are, in practice, a view of this market with others attached. Against regional totals of USD 94.8 million in 2025 and USD 162.8 million in 2034, it is the country the full report breaks out in detail.

The type pattern in the United States is the global one: 74.5% of 2025 revenue in Organic, 79% by 2034, against 7.78% growth in Organic taking it from 74.5% to 79%. Its 78% weight in North America means those movements carry straight into the regional totals. Revenue by type for the United States is reported separately in the full report.

Mangosteen extract sold in the United States is regulated by the Food and Drug Administration, primarily as a dietary supplement ingredient under the Dietary Supplement Health and Education Act. Suppliers are responsible for ensuring the ingredient is safe and truthfully labelled before it reaches the market, since supplements do not require pre-market approval the way drugs do. Manufacturers must follow current Good Manufacturing Practice regulations covering identity, purity, and composition testing, and any health claim on the label must be substantiated and cannot state that the product diagnoses, treats, or cures a disease. If the extract has not previously been marketed in the United States, it may also need to be reported as a New Dietary Ingredient. The Federal Trade Commission separately polices marketing claims for accuracy.

In the United States the field is Premier Specialties Inc., Carrubba Inc., Dermalab, Natural Remedies Private Limited, Shenzhen Sendi Biotechnology Co.Ltd., Wuhan Fortuna Chemical Co. Ltd., Changsha Staherb Natural Ingredients Co. Ltd., Wuhan Yuancheng Gongchuang Technology Co.Ltd., Shaanxi Kingsci Biotechnology Co. Ltd., Xi'an Changyue Phytochemistry Co. Ltd., Xi&rsquo, an DN Biology Co. Ltd., Andy Biotech (Xi&rsquo, an) Co. Ltd. and Guilin Layn Natural Ingredients Corp.and others.. Organic is both the largest line, at 74.5% of 2025 revenue, and the fastest-growing at 7.78%. The commercial size of that position is USD 94.8 million in 2025, moving to USD 162.8 million by 2034 across the forecast period.

Within North America, Canada accounts for 15% of regional revenue and 3.6% of the global total, worth USD 14.22 million in 2025 and USD 24.42 million by 2034.

USD 79 million of 2025 revenue is generated in Europe, 20% of the global mangosteen extract market on the way to USD 140.6 million by 2034. Among the five regions it ranks third by revenue in both years.

Its share moves to 19% by 2034, and the region keeps growing in absolute terms while others expand faster, a change in relative weight, not a decline in demand.

Segment composition follows the global pattern: Organic largest at 74.5% of 2025 revenue, Organic fastest at 7.78%. Europe is reported axis by axis and country by country in the full study.

Germany is the largest market within Europe, generating USD 23.7 million in 2025 and projected to reach USD 42.18 million by 2034. 30% of the region in the base year makes it the largest market here without making it the region. The region itself runs USD 79 million to USD 140.6 million over the same period, and this is the market carrying the country-level detail in the full report.

Demand in Germany follows the type mix reported at global level: Organic is the largest line at 74.5% of 2025 revenue, moving to 79% by 2034, while Organic grows fastest at 7.78% and takes its share from 74.5% to 79%. Its 30% weight in Europe means those movements carry straight into the regional totals. Germany carries its own type breakdown in the full report.

In Germany, mangosteen extract is governed by European Union food law alongside national enforcement bodies, chiefly the Federal Office of Consumer Protection and Food Safety. Because mangosteen has limited history of consumption in the European Union prior to its common cutoff date, extracts prepared in certain concentrated forms may fall under the Novel Food Regulation, requiring authorisation before sale unless an existing approved use can be demonstrated. Products marketed as food supplements must additionally meet the EU Food Supplements Directive, covering composition and labelling requirements, while any stated health benefit must be pre-approved under the Health Claims Regulation. General food labelling rules require clear listing of ingredients, allergens, and supplement-specific warnings. Enforcement runs through German food safety authorities working within the broader EU framework.

In Germany the field is Premier Specialties Inc., Carrubba Inc., Dermalab, Natural Remedies Private Limited, Shenzhen Sendi Biotechnology Co.Ltd., Wuhan Fortuna Chemical Co. Ltd., Changsha Staherb Natural Ingredients Co. Ltd., Wuhan Yuancheng Gongchuang Technology Co.Ltd., Shaanxi Kingsci Biotechnology Co. Ltd., Xi'an Changyue Phytochemistry Co. Ltd., Xi&rsquo, an DN Biology Co. Ltd., Andy Biotech (Xi&rsquo, an) Co. Ltd. and Guilin Layn Natural Ingredients Corp.and others.. Organic is both the largest line, at 74.5% of 2025 revenue, and the fastest-growing at 7.78%. A supplier weighted toward Europe is competing over a base of USD 79 million in 2025 reaching USD 140.6 million by 2034, 20% of global revenue at the start of that period.

France is sized at USD 17.38 million in 2025, rising to USD 30.93 million by 2034; 4.4% of global revenue and 22% of Europe. It is reported separately from Germany across every segmentation axis in the full report.

Within Europe, the United Kingdom accounts for 20% of regional revenue and 4% of the global total, worth USD 15.8 million in 2025 and USD 28.12 million by 2034.

USD 31.6 million of 2025 revenue is generated in Latin America, 8% of the global mangosteen extract market on the way to USD 62.9 million by 2034. Among the five regions it ranks fourth by revenue in both years.

By 2034 the share has moved up to 8.5%, so the region grows faster than the market's 7.08% and takes a larger part of the revenue added by 2034 than its 2025 weight implies.

Organic leads here as it does globally, at 74.5% of 2025 revenue, and Organic again grows fastest at 7.78%. Revenue for Latin America is broken out by every segmentation axis and by country in the full report.

Brazil is the largest market within Latin America, generating USD 15.8 million in 2025 and projected to reach USD 31.45 million by 2034. 50% of the region in the base year makes it the largest market here without making it the region. The region itself runs USD 31.6 million to USD 62.9 million over the same period, and this is the market carrying the country-level detail in the full report.

The type pattern in Brazil is the global one: 74.5% of 2025 revenue in Organic, 79% by 2034, against 7.78% growth in Organic taking it from 74.5% to 79%. Its 50% weight in Latin America means those movements carry straight into the regional totals. Revenue by type for Brazil is reported separately in the full report.

Mangosteen extract marketed in Brazil is regulated by the National Health Surveillance Agency, which classifies food ingredients and supplements and sets the conditions under which they may be sold. Depending on its intended use, the extract may be categorised as a food ingredient, a food supplement, or a functional food, each carrying its own registration or notification requirements before commercialisation. Suppliers must demonstrate that the ingredient meets established identity and quality parameters and that any functional or health claim aligns with what the agency permits for that category. Labelling must disclose composition, recommended use, and any cautionary statements in Portuguese, consistent with national food labelling rules. Importers bear responsibility for ensuring foreign-sourced extract complies with these same domestic standards before distribution.

In Brazil the field is Premier Specialties Inc., Carrubba Inc., Dermalab, Natural Remedies Private Limited, Shenzhen Sendi Biotechnology Co.Ltd., Wuhan Fortuna Chemical Co. Ltd., Changsha Staherb Natural Ingredients Co. Ltd., Wuhan Yuancheng Gongchuang Technology Co.Ltd., Shaanxi Kingsci Biotechnology Co. Ltd., Xi'an Changyue Phytochemistry Co. Ltd., Xi&rsquo, an DN Biology Co. Ltd., Andy Biotech (Xi&rsquo, an) Co. Ltd. and Guilin Layn Natural Ingredients Corp.and others.. Organic is where the volume is, at 74.5% of 2025 revenue, and it is growing fastest as well at 7.78%. The commercial size of that position is USD 31.6 million in 2025, moving to USD 62.9 million by 2034 across the forecast period.

Mexico is sized at USD 7.9 million in 2025, rising to USD 15.73 million by 2034; 2% of global revenue and 25% of Latin America. It is reported separately from Brazil across every segmentation axis in the full report.

USD 23.7 million of 2025 revenue is generated in Middle East and Africa, 6% of the global mangosteen extract market with USD 48.1 million projected for 2034. It is a marginal region on this axis, fifth by revenue throughout the period.

6.5% of global revenue sits here by 2034, up from the 2025 level, because it outgrows the market's 7.08%; the revenue added here is disproportionate to where the region started.

Segment composition follows the global pattern: Organic largest at 74.5% of 2025 revenue, Organic fastest at 7.78%. Middle East and Africa is reported axis by axis and country by country in the full study.

The largest single market in Middle East and Africa is Saudi Arabia, at USD 8.3 million in 2025 and USD 16.84 million in 2034. It accounts for 35% of regional revenue in the base year, the largest single share without dominating the region outright. The region itself runs USD 23.7 million to USD 48.1 million over the same period, and this is the market carrying the country-level detail in the full report.

Composition here matches the global split: the largest line is Organic at 74.5% of 2025 revenue, easing to 79% by 2034, and the fastest is Organic at 7.78%, from 74.5% to 79%. Because the country carries 35% of Middle East and Africa, a movement in its own mix shows up in the regional totals instead of being averaged away by neighbouring markets. Saudi Arabia carries its own type breakdown in the full report.

In Saudi Arabia, mangosteen extract used in food or supplement products is regulated by the Saudi Food and Drug Authority, which sets requirements for classification, registration, and labelling of imported and domestically produced ingredients. Supplement products generally require registration before they can be sold, with documentation confirming composition, safety, and manufacturing standards, while ingredients used purely as food additives are assessed against the authority's food safety requirements instead. Labelling must be presented in Arabic alongside any other language used, disclosing ingredients and directions for use, and health-related claims must be consistent with what the authority allows for that product category. Conformity with Gulf Cooperation Council technical standards, where applicable, is also expected of suppliers bringing the extract into the Saudi market.

In Saudi Arabia the field is Premier Specialties Inc., Carrubba Inc., Dermalab, Natural Remedies Private Limited, Shenzhen Sendi Biotechnology Co.Ltd., Wuhan Fortuna Chemical Co. Ltd., Changsha Staherb Natural Ingredients Co. Ltd., Wuhan Yuancheng Gongchuang Technology Co.Ltd., Shaanxi Kingsci Biotechnology Co. Ltd., Xi'an Changyue Phytochemistry Co. Ltd., Xi&rsquo, an DN Biology Co. Ltd., Andy Biotech (Xi&rsquo, an) Co. Ltd. and Guilin Layn Natural Ingredients Corp.and others.. Organic is where the volume is, at 74.5% of 2025 revenue, and it is growing fastest as well at 7.78%. A supplier weighted toward Middle East and Africa is competing over a base of USD 23.7 million in 2025, reaching USD 48.1 million by 2034 on the trajectory this study models.

1.5% of global revenue is generated in South Africa; USD 5.93 million in 2025, reaching USD 12.03 million in 2034, and 25% of Middle East and Africa.

Request this sample to see the full data tables and segment-level detail behind this analysis.

This report assesses the market across every segment, with revenue and a growth rate for each line in each year of the study period. It covers the drivers, trends, opportunities, restraints and challenges shaping growth, the competitive landscape and the companies profiled, and the research methodology behind every estimate. Segmentation is reported by Type, Application, Form, Extraction Method, Distribution Channel, and regional analysis covers Asia Pacific, North America, Europe, Latin America, Middle East and Africa, each broken out by country.